Asthma and rhinitis control in adolescents and young adults: A real‐world <scp>MASK</scp>‐air study-Reference-Cited by-同舟云学术

Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study

Published:2024-02 Issue:2 Volume:35 Page:
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatric Allergy Immunology

Author:

Sousa‐Pinto Bernardo¹²,Valiulis Arunas³⁴,Melén Erik⁵⁶^ORCID,Koppelman Gerard H.⁷,Papadopoulos Nikolaos G.⁸,Makela Mika⁹,Haahtela Tari⁹,Bonini Matteo¹⁰¹¹¹²,Braido Fulvio¹³¹⁴,Brussino Luisa¹⁵¹⁶,Cruz Alvaro A.¹⁷,Fiocchi Alessandro¹⁸^ORCID,Giovannini Mattia¹⁹²⁰^ORCID,Gemicioglu Bilun²¹,Kulus Marek²²,Kuna Piotr²³,Kupczyk Maciej²³,Kvedariene Violeta²⁴²⁵,Larenas‐Linnemann Désirée E.²⁶^ORCID,Louis Renaud²⁷²⁸,Morais‐Almeida Mario²⁹,Niedoszytko Marek³⁰,Ollert Markus³¹³²^ORCID,Pfaar Oliver³³^ORCID,Regateiro Frederico S.³⁴³⁵³⁶^ORCID,Roberts Graham³⁷³⁸³⁹^ORCID,Samolinski Boleslaw⁴⁰,Savouré Marine⁴¹⁴²,Taborda‐Barata Luis³⁶⁴³^ORCID,Toppila‐Salmi Sanna⁴⁴⁴⁵,Ventura Maria Teresa⁴⁶⁴⁷,Vazquez‐Ortiz Marta⁴⁸⁴⁹,Vieira Rafael José¹²,Fonseca Joao A.¹²,Yorgancioglu Arzu⁵⁰,Zuberbier Torsten⁵¹⁵²,Anto Josep M.⁵³⁵⁴⁵⁵,Bousquet Jean⁵¹⁵²⁵⁶^ORCID,Pham‐Thi Nhân⁵⁷⁵⁸⁵⁹,

Affiliation:

1. MEDCIDS – Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine University of Porto Porto Portugal

2. CINTESIS@RISE – Health Research Network, Faculty of Medicine University of Porto Porto Portugal

3. Interdisciplinary Research Group of Human Ecology, Institute of Clinical Medicine and Institute of Health Sciences Medical Faculty of Vilnius University Vilnius Lithuania

4. European Academy of Paediatrics, (EAP/UEMS‐SP) Brussels Belgium

5. Department of Clinical Science and Education, Södersjukhuset Karolinska Institutet Stockholm Sweden

6. Sach's Children and Youth Hospital, Södersjukhuset Stockholm Sweden

7. Beatrix Children's Hospital, Department of Pediatric Pulmonology and Pediatric Allergology, GRIACResearch Institute University of Groningen, University Medical Center Groningen Groningen The Netherlands

8. Allergy Department, 2nd Pediatric Clinic University of Athens Athens Greece

9. Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki Helsinki Finland

10. Department of Cardiovascular and Respiratory Sciences Universita Cattolica del Sacro Cuore Rome Italy

11. Department of Neurological, ENT and Thoracic Sciences Fondazione Policlinico Universitario A Gemelli – IRCCS Rome Italy

12. National Heart and Lung Institute (NHLI), Imperial College London London UK

13. Respiratory Clinic, Department of Internal Medicine University of Genoa Genoa Italy

14. IRCCS Ospedale Policlinico San Martino Genoa Italy

15. Department of Medical Sciences University of Torino Torino Italy

16. Allergy and Clinical Immunology Unit Mauriziano Hospital Torino Italy

17. Fundaçao ProAR, Federal University of Bahia and GARD/WHO Planning Group Salvador Bahia Brazil

18. Allergy, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico Rome Italy

19. Allergy Unit Meyer Children's Hospital IRCCS Florence Italy

20. Department of Health Sciences University of Florence Florence Italy

21. Department of Pulmonary Diseases, Cerrahpaşa Faculty of Medicine Istanbul University‐Cerrahpaşa Istanbul Turkey

22. Department of Pediatric Respiratory Diseases and Allergology Medical University of Warsaw Warsaw Poland

23. Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital, Medical University of Lodz Lodz Poland

24. Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine Vilnius University Vilnius Lithuania

25. Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine Vilnius University Vilnius Lithuania

26. Center of Excellence in Asthma and Allergy Médica Sur Clinical Foundation and Hospital México City Mexico

27. Department of Pulmonary Medicine CHU Liège Liège Belgium

28. GIGA I3 Research Group University of Liège Liège Belgium

29. Allergy Center CUF Descobertas Hospital Lisbon Portugal

30. Department of Allergology Medical University of Gdańsk Gdansk Poland

31. Department of Infection and Immunity Luxembourg Institute of Health Esch‐sur‐Alzette Luxembourg

32. Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis (ORCA) Odense University Hospital Odense Denmark

33. Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy University Hospital Marburg, Philipps‐Universität Marburg Marburg Germany

34. Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Institute of Immunology, Faculty of Medicine University of Coimbra Coimbra Portugal

35. Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine University of Coimbra Coimbra Portugal

36. UBIAir – Clinical & Experimental Lung Centre and CICS‐UBI Health Sciences Research Centre University of Beira Interior Covilhã Portugal

37. Faculty of Medicine University of Southampton Southampton UK

38. The David Hide Asthma and Allergy Centre, St Mary's Hospital Isle of Wight UK

39. NIHR Southampton Biomedical Research Centre University Hospital Southampton NHS Foundation Trust Southampton UK

40. Department of Prevention of Environmental Hazards, Allergology and Immunology Medical University of Warsaw Warsaw Poland

41. Université Paris‐Saclay, UVSQ, Univ. Paris‐Sud Villejuif France

42. Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP Villejuif France

43. Department of Immunoallergology Cova da Beira University Hospital Centre Covilhã Portugal

44. Department of Otorhinolaryngology Kuopio University Hospital and University of Eastern Finland Kupio Finland

45. Department of Allergy, Inflammation Center Helsinki University Hospital and University of Helsinki Helsinki Finland

46. Allergy and Clinical Immunology University of Bari Medical School Bari Italy

47. Institute of Sciences of Food Production, National Research Council (ISPA‐CNR) Bari Italy

48. Section of Inflammation, Repair and Development, Imperial College London National Heart and Lung Institute London UK

49. Department of Paediatrics Imperial College Healthcare NHS Trust London UK

50. Department of Pulmonary Diseases, Faculty of Medicine Celal Bayar University Manisa Turkey

51. Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

52. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology Berlin Germany

53. ISGlobal, Barcelona Institute for Global Health Barcelona Spain

54. Universitat Pompeu Fabra (UPF) Barcelona Spain

55. CIBER Epidemiología y Salud Pública (CIBERESP) Barcelona Spain

56. MASK‐air Montpellier France

57. Ecole Polytechnique de Palaiseau Palaiseau France

58. IRBA (Institut de Recherche Bio‐Médicale des Armées) Brétigny sur Orge France

59. Université Paris Cité Paris France

Abstract

AbstractBackgroundIn allergic rhinitis and asthma, adolescents and young adult patients are likely to differ from older patients. We compared adolescents, young adults and adults on symptoms, control levels, and medication adherence.MethodsIn a cross‐sectional study (2015–2022), we assessed European users of the MASK‐air mHealth app of three age groups: adolescents (13–18 years), young adults (18–26 years), and adults (>26 years). We compared them on their reported rhinitis and asthma symptoms, use and adherence to rhinitis and asthma treatment and app adherence. Allergy symptoms and control were assessed by means of visual analogue scales (VASs) on rhinitis or asthma, the combined symptom‐medication score (CSMS), and the electronic daily control score for asthma (e‐DASTHMA). We built multivariable regression models to compare symptoms or medication accounting for potential differences in demographic characteristics and baseline severity.ResultsWe assessed 965 adolescent users (15,252 days), 4595 young adults (58,161 days), and 15,154 adult users (258,796 days). Users of all three age groups displayed similar app adherence. In multivariable models, age groups were not found to significantly differ in their adherence to rhinitis or asthma medication. These models also found that adolescents reported lower VAS on global allergy, ocular, and asthma symptoms (as well as lower CSMS) than young adults and adults.ConclusionsAdolescents reported a better rhinitis and asthma control than young adults and adults, even though similar medication adherence levels were observed across age groups. These results pave the way for future studies on understanding how adolescents control their allergic diseases.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pai.14080

Reference23 articles.

1. BonnieR StroudC BreinerH et al.Investing in the Health and Well‐Being of Young Adults.2015. Accessed October 31 2023.https://www.ncbi.nlm.nih.gov/books/NBK284791/

2. Transition for Adolescents and Young Adults With Asthma

3. National, regional, and global causes of mortality in 5–19-year-olds from 2000 to 2019: a systematic analysis

4. A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper

5. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases;The Journal of Allergy and Clinical Immunology: In Practice;2024-08

2. Use of Technology to Improve Adherence in Allergy/Immunology;The Journal of Allergy and Clinical Immunology: In Practice;2024-07

3. Editorial comments on “Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study”;Pediatric Allergy and Immunology;2024-05